tiprankstipranks
Trending News
More News >
Can-Fite BioPharma Ltd. (IL:CANF)
:CANF
Israel Market

Can Fite Bio (CANF) Financial Statements

Compare
2 Followers

Can Fite Bio Financial Overview

Can Fite Bio's market cap is currently 17.88M. The company's EPS TTM is -440.410756828; its P/E ratio is ―; Can Fite Bio is scheduled to report earnings on November 21, 2025, and the estimated EPS forecast is -440.41. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Gross Profit$ 674.00K$ 743.00K$ 810.00K$ 853.00K$ 763.00K
Operating Income$ -8.13M$ -8.20M$ -10.10M$ -12.84M$ -14.14M
EBITDA$ -8.12M$ -8.18M$ -10.08M$ -12.83M$ -14.13M
Net Income$ -7.88M$ -7.63M$ -10.17M$ -12.60M$ -14.44M
Balance Sheet
Cash & Short-Term Investments$ 7.89M$ 8.92M$ 7.98M$ 19.14M$ 8.34M
Total Assets$ 9.12M$ 9.99M$ 9.28M$ 20.25M$ 9.52M
Total Debt$ 104.00K$ 40.00K$ 62.00K$ 124.00K$ 67.00K
Net Debt$ -4.72M$ -4.24M$ -2.92M$ -4.27M$ -8.20M
Total Liabilities$ 3.68M$ 3.75M$ 4.81M$ 5.87M$ 3.45M
Stockholders' Equity$ 5.44M$ 6.24M$ 4.47M$ 14.38M$ 6.07M
Cash Flow
Free Cash Flow$ -7.64M$ -8.44M$ -10.81M$ -9.87M$ -12.09M
Operating Cash Flow$ -7.64M$ -8.44M$ -10.80M$ -9.86M$ -12.06M
Investing Cash Flow$ 1.50M$ 498.00K$ 9.50M$ -14.51M$ -26.00K
Financing Cash Flow$ 6.71M$ 9.14M$ 0.00$ 20.46M$ 17.68M
Currency in USD

Can Fite Bio Earnings and Revenue History

Can Fite Bio Debt to Assets

Can Fite Bio Cash Flow

Can Fite Bio Forecast EPS vs Actual EPS